Publikationen und Abstracts 2011

Publikationen

Hepatitis-B-Virus: Sicherheit von labilen Blutprodukten.
Niederhauser C, Stolz M. pipette. 2011;6: 20-22.

Reverse vertical transmission of Hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.
Niederhauser C, Candotti D, Weingand T, Maier A, Tinguely C, Stolz M, Allain JP. J Hepatol. 2011:Oct 22.

Reducing the risk of hepatitis B virus transfusion-transmitted infection.
Niederhauser C. J Blood Med. 2011;2: 91-102.

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin C, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Lętowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW. Vox Sang. 2011;Sep 21. doi: 10.1111/j.1423-0410.2011.01506.x.

Genotypisierung von Spendern und Patienten.
Niederhauser C, Lejon Crottet S. Pipette 2011;5: 16-18.

Platelet Recruitment during Multiple Donor Platelet Apheresis Differs between Cell Separators.
Fontana S, Keller P, Mansouri Taleghani B. Transfusion Medicine and Hemotherapy 2011;38:195-198.

A novel Bweak hybrid allele lacks three enhancer repeats but generates normal AB0 transcript levels.
Thuresson B, Hosseini-Maaf B, Hult A.K, Hustinx H, Alan Chester M, Olsson M.L. Vox Sanguinis 2011;May 19. doi: 10.1111/j.1423-0410.2011.01497.x.

Recruitment of platelets, Leukocytes, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S, Rados L, Schmid P, Oppliger E Leibundgut K and Mansouri Taleghani B. Transfusion 2011;51:2034-2043.

Abstracts

Seroprevalence of antibodies to Borrelia burgdorferi in a healthy Swiss blood donor population.
Tinguely C, Engler O, Niederhauser C, Fontana S, Tschaggelar A, Strasser M, Mütsch M. Transfus Med Hemother. 2011;38(suppl1):44 P2.08.

Randomized controlled trial (RCT) comparing the transfusion efficacy of triple and double Amicus platelet concentrates collected in plasma or PAS III additive solution.
Fontana S, Summermatter R, Vogt M, Mauchle P, Lädrach A, Pellegrini A, Mansouri Taleghani B. Transfus Med Hemother. 2011;38(suppl1):61 P8.05.

A case-control study comparing high yield platelet (PLT) apheresis with Amicus V3.11 and Trima V5.1/5.2 cell separators.
Siderow A, Lädrach A, Fontana S. Transfus Med Hemother. 2011;38(suppl1):61 P8.06.

Development and Validation of an In-house High-throughput Blood Group Genotyping System.
Lejon Crottet S, Gowland P, Hustinx H, Fontana S, Niederhauser C. Pipette.2011;Nr.4:14 Vortrag3.

Swiss Rare Donor File: a cost-effective strategy for identifying Vel and KEL*04 (Kp(b)) negative donors.
Hustinx H, Münger E, Fontana S, Lejon Crottet S, Gowland P, Niederhauser C. Pipette.2011;Nr.4:16 Poster2.

Feasibility of triple platelet (PLT) apheresis donations with the intercept pathogen reduction system.
Fontana S, Pellegrini A, Summermatter R, Byland C. Vox Sanguinis. 2011;Vol.101 Suppl1:185 P-265.

Transfusion-transmitted HBV infection of newborns through HBV contaminated RBC.
Niederhauser C, Weingand T, Candotti D, Meier A, Tinguely C, Allain JP, Stolz M. Vox Sanguinis. 2011;Vol.101 Suppl1:211 P-328.

A serological and molecular screen for WRA antigen-positive blood donors in Switzerland.
Gowland P, Lejon S, Niederhauser C, Fontana S, Hustinx H. Vox Sanguinis. 2011;Vol.101 Suppl1:261 P-456.

Comparison of the transfusion efficacy of multiple dose platelet concentrates collected in plasma or PAS III additive solution.
Fontana S, Summermatter R, Vogt M, Lädrach A, Mauchle P, Pellegrini A, Mansouri Taleghani B. SMF Swiss Medical Forum. 2011;11(18:Suppl.55,93S P475. ¦ Vox Sanguinis. 2011;Vol.101 Suppl1:135 P-142.

Suivi de la collecte de doses définies de plaquettes lors d’une étude clinique d’efficacité transfusionnelle.
Fontana S, Summermatter R, Gerber R, Mauchle P, Pellegrini A, Barmettler D, Aegerter P and Payrat JM. Transfusion Clinique et Biologique, 25ième Congrès national de la SFTS Lyon. 2011;Vol.18-N3;P029: 346.

Fréquence de l’allèle Kidd null suisse est plus élevée que prévu – un host spot ?
Lejon S, Hustinx H, Fontana S, Niederhauser C and Gowland P. Transfusion Clinique et Biologique, 25ième Congrès national de la SFTS Lyon. 2011;Vol.18-N3;P089: 360.

Perte des antigènes Cromer et apparition d’un anticorps anti-IFC après transfusion et septicémie.
Fontana S, Cerdan P, Siegenthaler M, Niederhauser C, Passweg J, Ritz M and Hustinx H. Transfusion Clinique et Biologique, 25ième Congrès national de la SFTS Lyon. 2011;Vol.18-N3;P116: 368.